ARS Pharmaceuticals Operations, Inc.

ARS Pharmaceuticals Operations, Inc. is a San Diego-based biopharmaceutical company focused on needle-free alternatives for emergency allergy treatment. The company’s proprietary intranasal absorption technology enables epinephrine delivery without the need for injections. Its flagship product, neffy (epinephrine nasal spray), is the first FDA-approved needle-free epinephrine for the emergency treatment of anaphylaxis in adults and children aged 4 and older. ARS Pharma’s mission is to empower patients and caregivers to act immediately at the onset of severe allergic reactions.